SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017748
Filing Date
2024-05-03
Accepted
2024-05-03 17:04:00
Documents
19
Period of Report
2024-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44574
2 ex5-1.htm EX-5.1 26329
3 ex5-1_001.jpg GRAPHIC 8656
4 ex5-1_002.jpg GRAPHIC 10986
5 ex5-1_003.jpg GRAPHIC 12545
6 ex5-1_004.jpg GRAPHIC 4588
7 ex10-1.htm EX-10.1 103194
  Complete submission text file 0001493152-24-017748.txt   428493

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE envb-20240503.xsd EX-101.SCH 3012
9 XBRL LABEL FILE envb-20240503_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE envb-20240503_pre.xml EX-101.PRE 22357
22 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3827
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 24914244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)